The risks of symptomatic vaginal candidiasis after oral antibiotic therapy

T. M. Macdonald, P. H G Beardon, M. M. McGilchrist, D. G. McDevitt, I. D. Duncan, A. D. McKendrick

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

It is generally accepted that antibiotic use can result in vaginal fungal overgrowth, although evidence estimating the extent to which this causes symptomatic vaginitis is scant. In a study using the prescription of vaginal antifungal preparations as a surrogate measure of vaginal candidiasis, a cohort of women taking antibiotics had a higher incidence of vaginal candidiasis after antibiotic exposure than befo0rehand (relative risk 2.3; 95% confidence interval 1.9–3.0); this risk was highest in those aged 36–40 years (RR 6.0, 95% CI 2.9–12.5). The attributable risk was highest among those who were taking cephalosporins (AR 12.8% 95% CI 9.1–16.5). In a case—control study, comparing previous antibiotic exposure among women using vaginal antifungal agents and mathced controls, antibiotic exposure was higher among those using vaginal antifungal agents during the previous 23 days, with an odds ratio of 5.5 (95% CI 3.8–7.9).

Original languageEnglish
Pages (from-to)419-424
Number of pages6
JournalQJM
Volume86
Issue number7
DOIs
Publication statusPublished - 1 Jan 1993

Fingerprint

Oral Candidiasis
Anti-Bacterial Agents
Candidiasis
Antifungal Agents
Vaginitis
Therapeutics
Cephalosporins
Prescriptions
Odds Ratio
Confidence Intervals
Incidence

Cite this

Macdonald, T. M. ; Beardon, P. H G ; McGilchrist, M. M. ; McDevitt, D. G. ; Duncan, I. D. ; McKendrick, A. D. / The risks of symptomatic vaginal candidiasis after oral antibiotic therapy. In: QJM. 1993 ; Vol. 86, No. 7. pp. 419-424.
@article{7c47321c1a4d440ea6b04fccc6ca87a6,
title = "The risks of symptomatic vaginal candidiasis after oral antibiotic therapy",
abstract = "It is generally accepted that antibiotic use can result in vaginal fungal overgrowth, although evidence estimating the extent to which this causes symptomatic vaginitis is scant. In a study using the prescription of vaginal antifungal preparations as a surrogate measure of vaginal candidiasis, a cohort of women taking antibiotics had a higher incidence of vaginal candidiasis after antibiotic exposure than befo0rehand (relative risk 2.3; 95{\%} confidence interval 1.9–3.0); this risk was highest in those aged 36–40 years (RR 6.0, 95{\%} CI 2.9–12.5). The attributable risk was highest among those who were taking cephalosporins (AR 12.8{\%} 95{\%} CI 9.1–16.5). In a case—control study, comparing previous antibiotic exposure among women using vaginal antifungal agents and mathced controls, antibiotic exposure was higher among those using vaginal antifungal agents during the previous 23 days, with an odds ratio of 5.5 (95{\%} CI 3.8–7.9).",
author = "Macdonald, {T. M.} and Beardon, {P. H G} and McGilchrist, {M. M.} and McDevitt, {D. G.} and Duncan, {I. D.} and McKendrick, {A. D.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1093/oxfordjournals.qjmed.a068836",
language = "English",
volume = "86",
pages = "419--424",
journal = "QJM : an International Journal of Medicine",
issn = "1460-2725",
publisher = "Oxford University Press",
number = "7",

}

The risks of symptomatic vaginal candidiasis after oral antibiotic therapy. / Macdonald, T. M.; Beardon, P. H G; McGilchrist, M. M.; McDevitt, D. G.; Duncan, I. D.; McKendrick, A. D.

In: QJM, Vol. 86, No. 7, 01.01.1993, p. 419-424.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The risks of symptomatic vaginal candidiasis after oral antibiotic therapy

AU - Macdonald, T. M.

AU - Beardon, P. H G

AU - McGilchrist, M. M.

AU - McDevitt, D. G.

AU - Duncan, I. D.

AU - McKendrick, A. D.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - It is generally accepted that antibiotic use can result in vaginal fungal overgrowth, although evidence estimating the extent to which this causes symptomatic vaginitis is scant. In a study using the prescription of vaginal antifungal preparations as a surrogate measure of vaginal candidiasis, a cohort of women taking antibiotics had a higher incidence of vaginal candidiasis after antibiotic exposure than befo0rehand (relative risk 2.3; 95% confidence interval 1.9–3.0); this risk was highest in those aged 36–40 years (RR 6.0, 95% CI 2.9–12.5). The attributable risk was highest among those who were taking cephalosporins (AR 12.8% 95% CI 9.1–16.5). In a case—control study, comparing previous antibiotic exposure among women using vaginal antifungal agents and mathced controls, antibiotic exposure was higher among those using vaginal antifungal agents during the previous 23 days, with an odds ratio of 5.5 (95% CI 3.8–7.9).

AB - It is generally accepted that antibiotic use can result in vaginal fungal overgrowth, although evidence estimating the extent to which this causes symptomatic vaginitis is scant. In a study using the prescription of vaginal antifungal preparations as a surrogate measure of vaginal candidiasis, a cohort of women taking antibiotics had a higher incidence of vaginal candidiasis after antibiotic exposure than befo0rehand (relative risk 2.3; 95% confidence interval 1.9–3.0); this risk was highest in those aged 36–40 years (RR 6.0, 95% CI 2.9–12.5). The attributable risk was highest among those who were taking cephalosporins (AR 12.8% 95% CI 9.1–16.5). In a case—control study, comparing previous antibiotic exposure among women using vaginal antifungal agents and mathced controls, antibiotic exposure was higher among those using vaginal antifungal agents during the previous 23 days, with an odds ratio of 5.5 (95% CI 3.8–7.9).

UR - http://www.scopus.com/inward/record.url?scp=0027199010&partnerID=8YFLogxK

U2 - 10.1093/oxfordjournals.qjmed.a068836

DO - 10.1093/oxfordjournals.qjmed.a068836

M3 - Article

C2 - 8210296

AN - SCOPUS:0027199010

VL - 86

SP - 419

EP - 424

JO - QJM : an International Journal of Medicine

JF - QJM : an International Journal of Medicine

SN - 1460-2725

IS - 7

ER -